Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK4 | P11802 | 7/20 | 0.55 |
| ▸ | CCND1 | P24385 | 7/20 | 0.55 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.47 |
| ▸ | IMPDH2 | P12268 | 2/20 | 0.44 |
| ▸ | FEN1 | P39748 | 1/20 | 0.44 |
| ▸ | PLK4 | O00444 | 1/20 | 0.44 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.44 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.44 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.44 |
| ▸ | AKT3 | Q9Y243 | 1/20 | 0.44 |
| ▸ | JAK2 | O60674 | 1/20 | 0.42 |
| ▸ | GABRP | O00591 | 1/20 | 0.42 |
| ▸ | GABRD | O14764 | 1/20 | 0.42 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.42 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.42 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.42 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.42 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.42 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.42 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30715257 | 1.00 | CDK4 (0.55) | CDK4CCND1TNKS2IMPDH2FEN1 | |
| SCHEMBL29751876 | 1.00 | CDK4 (0.55) | CDK4CCND1TNKS2IMPDH2FEN1 | |
| SCHEMBL27969034 | 0.88 | IMPDH2 (0.52) | CDK4CCND1IMPDH2PLK4MAPK9 | |
| SCHEMBL19494764 | 0.87 | CDK4 (0.56) | CDK4CCND1PLK4MAPK9LIMK1 | |
| SCHEMBL29888674 | 0.86 | CDK4 (0.50) | CDK4CCND1TNKS2FEN1JAK2 | |
| SCHEMBL28368134 | 0.86 | CDK4 (0.51) | CDK4CCND1IMPDH2PLK4MAPK9 | |
| SCHEMBL18429996 | 0.85 | AHR (0.52) | CDK4CCND1IMPDH2GABRPGABRD | |
| SCHEMBL30441967 | 0.85 | AHR (0.52) | CDK4CCND1IMPDH2GABRPGABRD | |
| SCHEMBL1669833 | 0.84 | IMPDH2 (0.55) | CDK4CCND1IMPDH2PLK4MAPK9 | |
| SCHEMBL1177888 | 0.84 | IMPDH2 (0.55) | CDK4CCND1IMPDH2PLK4MAPK9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117402102-A | Diamine containing carbazole moieties and polyimide gas separation membrane prepared from diamine and method | 西北工业大学 | 2024-01-16 | — | — | CN | claimed |
| US-20240208991-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | LG CHEM, LTD (KR) | 2024-06-27 | — | — | US | disclosed |
| CN-117402102-A | Diamine containing carbazole moieties and polyimide gas separation membrane prepared from diamine and method | 西北工业大学 | 2024-01-16 | — | — | CN | disclosed |
| WO-2023012711-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | 주식회사 엘지화학 | 2023-02-09 | — | — | WO | disclosed |
| CN-103183691-B | Assorted benzo [cd] pyrene derivatives of 6-mesitylene base-6H-6-boron of containing substituted or non-substituted carbazyl and preparation method and application and containing its luminescent device | WEIXINNUO DISPLAY TECH CO., LTD. (CN) | 2016-05-25 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240208991-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | CRY1, CCNL2, UBE2L3 | CDK4 506/4885CCND1 29/4885TNKS2 4513/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.